(Q51802017)

English

Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.

scientific article published in November 2006

Statements

Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit